Tag: Gevo

Gevo says isobutanol batch times reduced 50%, production set to rise at Luverne

Gevo says isobutanol batch times reduced 50%, production set to rise at Luverne

September 18, 2014 |

In Colorado, Gevo reported an update on the progress of the Side-by-Side operational mode of its plant in Luverne, MN. In the beginning of June, Gevo commenced the co-production of isobutanol and ethanol, with one fermenter dedicated to isobutanol production and three fermenters dedicated to ethanol production. With the completion of the last phase of […]

Read More

And now, strangest of all wonders, more on Butamax vs Gevo

And now, strangest of all wonders, more on Butamax vs Gevo

September 10, 2014 |

It’s like the selling of Ginsu knives, the legal dispute between these two companies. No matter how much you hear….but wait, there’s more! This week, we heard from Butamax that the District Court of Delaware has issued an order scheduling two further rounds of patent infringement actions pending between Butamax and Gevo for resolution. The […]

Read More

What we know about Gevo’s stock run-up, trading volume surge and the rumors

What we know about Gevo’s stock run-up, trading volume surge and the rumors

September 5, 2014 |

We’re receiving a heavy flow of queries regarding Gevo in the mailbox. Here’s what we know: Informed industry sources say there have been “substantial layoffs” at the company’s corporate offices in Colorado — which is to say, some key industry people are on the job hunt. Our usual contacts at Gevo are in a “neither […]

Read More

Butamax will pay attorneys’ fees for Gevo litigation

Butamax will pay attorneys’ fees for Gevo litigation

August 28, 2014 |

In Delaware, Butamax’s victory in Gevo’s lawsuit for copyright infringement will still cost the company, as the judge in the case refused to award attorneys’ fees to Butamax. According to US District Court Judge Sue Robinson, Gevo hadn’t pointlessly filed suit against Butamax, leaving the latter financially responsible for its attorneys’ fees. The lawsuit, which […]

Read More

Gevo boosts revs in Q2, but losses widen; aims for break-even at Luverne by year end

Gevo boosts revs in Q2, but losses widen; aims for break-even at Luverne by year end

August 20, 2014 |

In Colorado, Gevo announced a net loss for Q2 2014 of $17.2 million compared to $15.2M during Q2 2013, on Q2 revenues of $7.7M compared to $1.9M for Q2 2013. The increase in revenue during 2014 is primarily a result of the production and sale of ethanol and distiller’s grains of $5.5 million following the […]

Read More

Gevo expects Lucerne plant to break even by end of 2014

Gevo expects Lucerne plant to break even by end of 2014

August 4, 2014 |

In Minnesota, Gevo expects that its second-generation ethanol and isobutanol plant in Lucerne will break even by the end of 2014. It expects to produce 1 million gallons of isobutanol by the end of the year and 3 million gallons by the end of 2015. The facility also produces 18 million gallons of ethanol.  

Read More

Gevo sells $18 million in stock to fund Luverne project completion

Gevo sells $18 million in stock to fund Luverne project completion

July 31, 2014 |

In Colorado, Gevo announced that it has priced its underwritten public offering of common stock units. Gevo announced that it has agreed to sell 30,000,000 common stock units. Each common stock unit consists of one share of common stock and a warrant to purchase 0.5 shares of common stock, at a public offering price of […]

Read More

Gevo reports targeting “break-even at Luverne by year-end”.

Gevo reports targeting “break-even at Luverne by year-end”.

July 30, 2014 |

“By running the SBS we have dramatically reduced our cash burn at the plant and we are targeting breakeven at Luverne by year end,”  Gevo CEO Pat Gruber is reporting. Gevo also reported that Isobutanol yields have reached >90% of target based on starch content, up from approximately 70% prior to running its new side-by-side […]

Read More

Back in My Arms Again: The Supremes take on patent law in the era of synthetic biology

Back in My Arms Again: The Supremes take on patent law in the era of synthetic biology

July 18, 2014 |

Key ruling in Gevo, Butamax case links it to the upcoming Teva case, going before the Supreme Court this fall. In Colorado, Gevo filed a fascinating 8-K this week, relating that a United States District Court judge granted a motion to stay the patent litigation action brought by Butamax. The District Court’s decision postpones the […]

Read More

Branson: “We’re killing the world”

Branson: “We’re killing the world”

June 25, 2014 |

Branson at BIO. Branson on bio. And some of Branson’s bio. Sir Richard Branson joined BIO CEO Jim Greenwood on stage at the BIO International Convention for a talk on enterprises, the entrepreneurial spirit, a spirit of adventure. And the founder of brands ranging from Virgin Records to Virgin Galactic shared his views on the […]

Read More